-
Camelid-based CAR T cells targeting CD33 in acute myeloid leukemia
19 Feb 2025 18:30 GMT
Immuno-oncology
In a recently published study, researchers from Cima Universidad de Navarra and collaborators presented a novel SdAb-based CAR T-cell discovery platform that allows the generation, characterization and selection of SdAbs by several …
-
Effect of Age, Sex and Season on Acute Myeloid Leukemia Clinical Characteristics: A Retrospective Study
17 Feb 2025 14:50 GMT
… reference significance.
Abbreviations
AML, acute myeloid leukemia; FAB, French-American-British … genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG). Leukemia … associated molecular profiles in acute myeloid leukemia defined by comprehensive …
-
Tambiciclib/Zanubrutinib Yields Promising Responses in R/R DLBCL
22 Feb 2025 00:12 GMT
… very advanced clinical development in acute myeloid leukemia, we are continuously working … in relapsed or refractory acute myeloid leukemia.3,4
SELLAS announces … SLS009 in relapsed/refractory acute myeloid leukemia patients. News release. SELLAS …
-
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
21 Feb 2025 21:57 GMT
… cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS …
-
Room to Grow Event To Help Personalize Hospital Spaces
21 Feb 2025 16:16 GMT
… and her brave fight against acute myeloid leukemia. Julie Liechty, Ellison’s mother …
-
Karyotype Evolution in MDS and AML With TP53 Mutations
21 Feb 2025 14:53 GMT
… evolution of myelodysplastic syndrome and acute myeloid leukemia with TP53 mutations,” published in … patients with myelodysplastic syndrome or acute myeloid leukemia with TP53 mutations (MDS…
-
Tuspetinib Triplet Is Safe and Has Antileukemic Activity in Newly Diagnosed AML
21 Feb 2025 14:24 GMT
… , among patients with newly diagnosed acute myeloid leukemia (AML) showed acceptable safety and …
-
Carson Kiser
21 Feb 2025 11:22 GMT
… 2022, Carson was diagnosed with Acute Myeloid Leukemia. Through all of his hospital …
-
Foundation Medicine teams up with Sumitomo Pharma America to advance treatment for patients with acute leukaemia with NPM1 mutations using FoundationOne Heme platform
21 Feb 2025 05:52 GMT
… . Approximately 30 per cent of acute myeloid leukemia (AML) patients have NPM1 mutations …
-
Whole Exome Sequencing Market Expansion Projected Growth to USD 13.62 Billion by 2034
21 Feb 2025 05:18 GMT
… Latest Healthcare Trends and Insights
Acute Myeloid Leukemia Treatment Market: https:/… .marketresearchfuture.com/reports/acute-myeloid-leukemia-treatment-market-3223
Tracheostomy Products …